The team at iCare have issued a mandatory software update for iCare HOME2 Self-tonometers.
The concept of delivering a drug to protect retinal ganglion cells (RGCs) is not something that is currently done clinically, but as a complement to IOP lowering, may be an important glaucoma management tool.
Glaucoma Australia has been recognised by UTS Orthoptics as providing outstanding opportunities for clinical education. The charity was presented with an award for the NGO that has offered the most clinical placements sessions in 2021/22 to UTS Orthoptics students.
Due to the unprecedented nature of the COVID-19 pandemic, many people experienced disruptive health behaviours, such as a lack of compliance when taking medications.
Sydney-based ophthalmologist, Dr David Weschler, recently took part in a Live Q&A with Glaucoma Australia where he answered some of the most commonly asked questions about laser and surgery.
A 12-month clinical trial to examine the validity of home-monitoring for glaucoma patients using a novel software app has been successfully completed by a team of Australian researchers.
Glaucoma can affect our vision and the ability to drive safely. It is important to be aware of how glaucoma can influence driving as well as the standard your vision must meet to be able to legally hold a driver’s licence.
Since being diagnosed with glaucoma, I have been using several types of eye drops for 42 years.
We relocated in late 2020, so I had to find a new eye specialist.